menu
    • menu

    Company profile for PharmaMar

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    PharmaMar is a company focused on oncology and committed to research and development which takes inspiration from the sea to discover molecules with antitumor activity. We are an integrated company that seeks innovative products to provide healthcare professionals with new tools to treat cancer. PharmaMar’s commitment to patients and to research has made it a world leader in the discovery of antitumor drugs of marine origin....
    PharmaMar is a company focused on oncology and committed to research and development which takes inspiration from the sea to discover molecules with antitumor activity. We are an integrated company that seeks innovative products to provide healthcare professionals with new tools to treat cancer. PharmaMar’s commitment to patients and to research has made it a world leader in the discovery of antitumor drugs of marine origin. Our strong commitment to oncology translational research along with our deep understanding of the marine biodiversity of our oceans is placing us at the head of marine biotechnology.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    PharmaMarSpain_new Flag
    Country
    Country
    Spain
    Address
    Address
    Avda. De los Reyes, 1 Colmenar Viejo, Madrid 28770, ES
    Telephone
    Telephone
    +34 91 846 6000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://pharmamar.com/?lang=en
    Linkedin
    Linkedin
    https://www.linkedin.com/company/pharmamar
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/phrmmar

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    PharmaMar Gets Approval of Zepzelca For Metastatic Small Cell Lung Cancer
    PharmaMar Gets Approval of Zepzelca For Metastatic Small Cell Lung Cancer

    09 Mar 2023

    // KALKINEMEDIA

    https://kalkinemedia.com/au/news/healthcare/brief-pharma-mar-gets-approval-of-zepzelca-for-treatment-of-metastatic-small-cell-lung-cancer-in-switzerland

    KALKINEMEDIA
    09 Mar 2023
    Share Share
    PharmaMar initiates first human clinical trial of a new molecule, PM534
    PharmaMar initiates first human clinical trial of a new molecule, PM534

    30 Dec 2022

    // PRESS RELEASE

    https://pharmamar.com/en/pharmamar-initiates-first-human-clinical-trial-of-a-new-molecule-pm534-for-cancer-patients/

    PRESS RELEASE
    30 Dec 2022
    Share Share
    PharmaMar leads the ONCOLIBERYX consortium together with four research centers
    PharmaMar leads the ONCOLIBERYX consortium together with four research centers

    02 Dec 2022

    // PRESS RELEASE

    https://asebio.com/en/news-events/news/pharmamar-leads-oncoliberyx-consortium-together-four-research-centers-develop-new

    PRESS RELEASE
    02 Dec 2022
    Share Share
    PharmaMar says potential COVID-19 treatment shows efficacy against Omicron
    PharmaMar says potential COVID-19 treatment shows efficacy against Omicron

    10 Jan 2022

    // Inti Landauro REUTERS

    https://www.reuters.com/markets/europe/spains-pharmamar-says-potential-covid-19-treatment-shows-efficacy-against-2022-01-11/

    Inti Landauro REUTERS
    10 Jan 2022
    Share Share
    PharmaMar signs a new licensing and commercialization agreement with Eczacibasi
    PharmaMar signs a new licensing and commercialization agreement with Eczacibasi

    23 Dec 2021

    // PRNEWSWIRE

    https://www.prnewswire.co.uk/news-releases/pharmamar-signs-a-new-licensing-and-commercialization-agreement-with-eczacibasi-for-lurbinectedin-in-turkey-826674247.html

    PRNEWSWIRE
    23 Dec 2021
    Share Share
    PharmaMar, Jazz Announce Initiation of Confirmatory Phase 3 Trial of Zepzelca
    PharmaMar, Jazz Announce Initiation of Confirmatory Phase 3 Trial of Zepzelca

    11 Dec 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/pharmamar-and-jazz-pharmaceuticals-announce-initiation-of-confirmatory-phase-3-clinical-trial-of-zepzelca-lurbinectedin-for-the-treatment-of-patients-with-relapsed-small-cell-lung-cancer-301442832.html

    PRNEWSWIRE
    11 Dec 2021
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact PharmaMar and get a quotation

    PharmaMar is a supplier offers 2 products (APIs, Excipients or Intermediates).

    Find a price of Trabectedin bulk with DMF, JDMF offered by PharmaMar

    Find a price of Lurbinectedin bulk with DMF offered by PharmaMar

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search